Funds raised to be used for developing technologies for the diagnosis and treatment of chronic diseases
HealthTech startup FutureCure Health has secured around US$ 4 million in Series A funding led by RVCF India Growth Fund, Unicorn India Ventures, Kotak Investment Advisors Limited, and other investors.
FutureCure aims to help patients with migraine and other chronic diseases. The funding will be used to further develop various technologies, FDA approvals, and global expansion.
Rajneesh Bhandari, Founder, FutureCure said that FutureCure is developing cutting-edge technologies to diagnose and treat chronic diseases like migraine, dizziness, etc. FutureCure plans to launch various technologies for migraine patients, including wearable Neuromodulation and Biofeedback device. In addition, the digital therapeutics app will help identify the triggers using AI and help manage lifestyle changes. The interactive app will also provide Cognitive Behavioral Therapy (CBT).
Dr Anita Bhandari, Co-founder, FutureCure shared that migraine affects over 12 per cent of the global population. The incidence is much higher than diabetes or cardiac disease, especially in the age group of 20 to 50 years, which are the most productive years of a person’s life. Technological interventions by FutureCure will help millions of patients manage their migraine and other chronic diseases.